Peer Review History
| Original SubmissionOctober 17, 2021 |
|---|
|
PONE-D-21-31219Serial Histological Changes in the Cartilaginous Eustachian Tube in the Rat Following Balloon DilationPLOS ONE Dear Dr. Hong Ju Park, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by January 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ewa Tomaszewska, DVM Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on (1) methods to alleviate suffering, (2) methods of anesthesia and/or analgesia, and (3) basic housing and health monitoring 3. As part of your revision, please complete and submit a copy of the Full ARRIVE 2.0 Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://arriveguidelines.org/sites/arrive/files/Author%20Checklist%20-%20Full.pdf (PDF). Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the manuscript presented for the review the Authors describe the histological changes in the Eustachian tube (ET) after balloon dilation procedure (ETBD) at different intervals of time. I find the subject interesting and purposeful in the aspect of understanding processes that occur in the tissues after ETBD, which may result in the improvement of methodology and success rate of the procedure. A basic histological technique was used in this study to assess the epithelium, submucosa and the lumen of the ET. A series of morphometric analyses were also conducted to shed a light on the significance of the histological observations. However, the manuscript was prepared carelessly and thus this article could be suitable for publication in PlosOne journal after major revisions. Firstly, the Authors did not use the continuous line numbering which should be included according to a submission guideline and it would be helpful in preparing the review. The English language should be improved throughout the whole manuscript. For example: “A proposed underlying mechanism of ETBD is microtears in the…” – a mechanism is the process. Microtears are not a mechanism. “The rats were randomly assigned to four groups of each five for serial…” - I guess there were 5 rats in each of four groups but the sentence is incorrect, “All rats were sacrificed immediately, 1 week, 4 weeks and 12 weeks.” – maybe adding “after ETBD” would make the sentence more understandable. “Normal Histological Findings for the Rat Eustachian Tube” – Were the histological findings normal or were they conducted in normal tissue?. “… worsening of the luminal stricture” – Can luminal stricture get worse? It is difficult to point out all the language discrepancies without line numbers. ABSTRACT and INTRODUCTION. The aim of the study should be clearly pointed and precise. The statement that some issues “remain unclear” is insufficient and does not include the purpose of the study. The last sentence in the “introduction” should include not only the histological observations but also the morphometry and time intervals in which the alterations were observed. MATERIALS AND METHODS. In “Animals” the sentences referring to conditions of animal housing and adaptation should be put before the description of the study. The method of anaesthesia should be described as it was done in the “Fluoroscopic Eustachian tube balloon dilation”. If the method is the same, it should be described when it appears in the text for the first time. Moreover, the Authors divide 20 animals into 4 groups but in “Histopathologic examination” section there are five groups mentioned with normal (before) group (probably from the right ear, but from which rats?). The division into study groups should be explained more precisely. “Histopathologic examinations” should be changed to Histological examinations in accordance with the title of the manuscript. It should be also stated, how many slides were used from every animal for the morphological observations and how many microphotographs were taken for the morphometry (number of data taken into statistics). It should be explained how the depth of the submucosa relates to the fibrosis. Changes in the dimensions of the submucosa may be caused by different factors. Histopathological lesions should be marked on the figures if there were such alterations. Then they may be analysed morphometrically. In this case, the presence of fibrosis is a speculation. “Statistical analysis”. The Mann Whitney U test is a nonparametric test. It should be explained why such test was used for the analyses. It should be mentioned if all the data did not meet the assumptions for the parametric test? For example normality of the distribution or homogeneity of variance. “A p-value of < 0.05 was considered statistically significant.” Is a p-value significant or the differences between groups? (Another unfortunate language expression). RESULTS. If the Authors decide to emphasize the significance of the changes by adding “(p<0,05)” at the end of sentence they should follow this rule everywhere and not only in selected places. After some of the sentences, the Authors put “p=0,03”… does it mean that the result is ambiguous with p-value close to 0,05? After p-value, the name of the test should also be mentioned (also in legends to figures). In “Serial changes in the tubal cartilage after ETBD” the Authors stated that a fracture lines were identified in 14 rats’ ET. After that the Authors write: “All the cartilage fracture lines were observed immediately after ETBD” which gives only 5 rats (immediately group) and not 14. It should be explained more precisely. DISCUSSION. How the paragraph “In the urethra,…” relates to the changes in ET? REFERENCES. The names of the Journals should be abbreviated in references: 24, 25, 29, 34, 37 and 41. FIGURES AND FIGURE LEGENDS. The figures should contain markers of different structures of interest explained in the legends e.g. ET lumen, epithelium, Goblet cells, blood vessels, cartilage etc. for the readers who are not familiar with histology. The values on the scale bars in Fig 1 A,B,C and Fig 6 are not visible. The Authors should decide if they put the values on the scale bar or in the legends and follow their rule in all figures. In the Legends to figures, the Authors should avoid descriptions which are intended to be in the Results section. The H&E abbreviation should be used in all figures instead of full names. The letters “A,B,C” should be put at the beginning or at the end of the particular legend (the same arrangement in all figures). In the figure 7, the order of the parameters should be changed according to the legend to figure 7. The significant changes in the submucosa should be marked on the slides (e.g. fibrotic changes). Another minor comments. After “Seongnam, Korea” there are 2 parentheses. “Ad libitum” should be in italics. In every “Fig.” there should be no dot. Abbreviation “BD” was not explained in the text. There was only ETBD. Reviewer #2: The subject of this manuscript is interesting, as well as the obtained results. Unfortunately, the manuscript is not well written. Especially the methodological part requires major improvements. The manuscript cannot be published in this form. Material and Methods -It is said: In order to quantify changes in any of these aspects of the epithelium, the length of the epithelium exhibiting goblet cells (why the number of cells was not calculated?), and the level ( what does level mean – area, depth or length?) of squamous metaplasia or epithelial hyperplasia were measured and divided by the whole perimeter of the ET lumen in the corresponding slide (the charts in Figure 4 give percentages). The authors did not clearly describe the methodology for quantifying these data. It is not clear to the reader how the authors made these calculations. - The authors should use -blood vessels rather than vessels - other staining should be used to identify fibrosis in the submucosa, e.g. Masson-Goldner's trichrome staining - This method would clearly visualize collagen fibers in the tissue In the statistical analysis section there is no information on the presentation of data (as mean± SEM or SD?) Results It is said: the epithelial cells at the nasopharyngeal end were columnar and contained goblet cells. The epithelial cells at the cartilaginous end were more cuboidal in shape and contained few secretory mucous cells - These sentences are imprecise as its suggest that the epithelial cells contained secretory cells (the same applies to the description of Figure 1). Rather it should be: for example, the cartilaginous end epithelium consists of cuboidal and secretory cells. - The authors write: The epithelial cells at the nasopharyngeal end of the ET rat were desquamated immediately after ETBD. It should be written - they were destroyed or damaged. - It is said: At 4 weeks post-procedure, the epithelial hyperplasia decreased, and the original morphology was finally recovered at 12 weeks post-ETBD (Fig. 3). But in the earlier description, the authors did not mention anything about hyperplasia (here it appears for the first time, so it is difficult to understand when the authors write that the hyperplasia has decreased). - The higher magnifications of the photos in Figure 2 are not sharp - The authors should mark in Figure 3 the places where squamous metaplasia and hyperplasia occur. - the data shown in the graphs (especially Figures 4 and 5A) have large SEM or standard deviations??- which proves the large dispersion of data Discussion -Based on the analysis of the depth of the submucosa, the authors conclude that there was an increase in fibrosis, however, the authors did not perform any analyzes confirming the fibrosis. It is worth using other staining that will confirm the fibrosis (e.g. the mentioned Masson-Goldner staining). -the authors did not discuss the observed increase in vascularity in the submucosa. How to explain increased angiogenesis? - Linguistic proofreading needed!! ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-31219R1Serial histological changes in the cartilaginous Eustachian tube in the rat following balloon dilationPLOS ONE Dear Dr. Hong Ju Park, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 29 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ewa Tomaszewska, DVM Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript entitled: “Serial histological changes in the cartilaginous Eustachian tube in the rat following balloon dilation” is interesting and purposeful in the aspect of understanding processes that occur in the tissues after Eustachian tube ballon dilation. The Authors have assessed the epithelium, submucosa and the lumen of the ET using a basic histological technique enriched with morphometric analyses. The Authors have put a great effort to improve their manuscript after first revision. My comments and suggestions were taken into consideration, however there are still some minor issues that should be revised: 1. In References section, literature positions 21 and 24 are the same. After deleting one of them the numbers in the text should be corrected. 2. In References some names of journals are still not abbreviated: Reference 25: J Vasc Interv Radiol Reference 29: J Pharm Bioallied Sci Reference 34: Int J Pediatr Otorhinolaryngol Reference 38: Am J Otolaryngol 3. Figures and Figure legends In Fig 3 and 4 the white arrowheads are barely visible After * in fig 5 and 6 there should be: *statistically significant differences for p<0.05, Mann-Whitney U test. In S1 Fig. there should be a scale bar or magnification indicated in the legend. In my opinion, the manuscript is suitable for publication in PLOS ONE after minor revision. Reviewer #2: The work has been corrected in accordance with the comments of the reviewer, but I do have some remark, however. I see ambiguity in the description of Figure 4 (lines 457-460) and the description of the Results (lines 190-192) - what exactly did the authors want to write - epithelial hyperplasia or squamous metaplasia? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Serial histological changes in the cartilaginous Eustachian tube in the rat following balloon dilation PONE-D-21-31219R2 Dear Dr. Hong Ju Park, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ewa Tomaszewska, DVM Ph.D Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The work has been corrected in accordance with the comments of the reviewer. This manuscript is accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-21-31219R2 Serial histological changes in the cartilaginous Eustachian tube in the rat following balloon dilation Dear Dr. Park: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ewa Tomaszewska Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .